Vaxart (VXRT) EBITDA Margin (2009 - 2026)
Vaxart (VXRT) posted EBITDA Margin of -45.73% for Q2 2026, down 14.50 percentage points from -31.23% a year earlier and down 61.79 percentage points from the prior quarter.
Powered by 
Analysis
Vaxart (VXRT) EBITDA Margin (2009 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EBITDA Margin at Vaxart was 18.77%, up 76.50 percentage points year-over-year; for FY2025, it came in at 11.23%, up 211.38 percentage points from FY2024.
- Annual EBITDA Margin has increased for three consecutive years, with a five-year change of +689.93 percentage points (FY2020 to FY2025).
- In prior years, Vaxart's EBITDA Margin was -200.15% in FY2024 (+812.49 pp), -1012.64% in FY2023 (+100652.78 pp), -101665.42% in FY2022 (-93981.12 pp) and -7684.30% in FY2021 (-7005.61 pp).
- The Q2 2026 figure stands as the lowest quarterly EBITDA Margin since Q1 2025.
- On a year-over-year basis, EBITDA Margin increased in seven of the last eight quarters, with an average year-over-year change of +304.96 percentage points.
- The strongest year-over-year quarter for EBITDA Margin in the past five years was Q4 2023, with a gain of 132496.49 percentage points; the weakest was Q4 2022, with a drop of 101841.40 percentage points.
- According to Business Quant data, EBITDA Margin for the three prior quarters was 16.06% (Q1 2026), 55.14% (Q4 2025) and -7.91% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 36.69% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 32.68% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 46.88% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 40.60% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 39.77% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 46.62% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 50.63% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 42.49% |
| 10 | Vaxart | 87.73 Mn | 22.23 Mn | - | -150.76% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -150.76% |
| Jun 30, 2026 | -45.73% |
| Mar 31, 2026 | 16.06% |
| Dec 31, 2025 | 55.14% |
| Sep 30, 2025 | -7.91% |
| Jun 30, 2025 | -31.23% |
| Mar 31, 2025 | -60.78% |
| Dec 31, 2024 | -60.95% |
| Sep 30, 2024 | -248.35% |
| Jun 30, 2024 | -219.39% |
| Mar 31, 2024 | -1,003.81% |
| Dec 31, 2023 | -448.97% |
| Sep 30, 2023 | -749.98% |
| Jun 30, 2023 | -1,538.07% |
| Mar 31, 2023 | -3,482.96% |
| Dec 31, 2022 | -132,945.45% |
| Mar 31, 2022 | -27,817.65% |
| Dec 31, 2021 | -31,104.05% |
| Sep 30, 2021 | -8,115.00% |
| Jun 30, 2021 | -13,198.21% |
API Access
Vaxart EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=VXRT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "VXRT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=VXRT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();